Latest Edwards Lifesciences News & Updates

See the latest news and media coverage for Edwards. We track all announcements, press releases, and industry mentions in real time, all in one place.

Edwards Lifesciences (Edwards)

Structural heart medical device manufacturer

edwards.com

Headquarters: Irvine, United States
Founded year: 1958
Company type: Public company
Number of employees: 10,000+

Last updated Today

Latest news about Edwards Lifesciences (Edwards)

In short: Edwards Lifesciences secured key FDA approvals and reported strong 2026 growth, despite terminating a $945 million merger due to FTC objections.

Company announcements

May 4 Edwards

Edwards Lifesciences announces CFO appointment

Theodora Mistras succeeds Scott Ullem effective end of May 2026. She joins from Viatris.

May 2 Edwards

Edwards announces 10-year COMMENCE trial results

Results show 97.9% freedom from structural valve deterioration for RESILIA tissue in aortic valves. Data presented at AATS meeting.

April 23 Edwards

Edwards announces Q1 2026 financial results

The earnings release includes Forward-Looking Statements and Non-GAAP Reconciliations.

April 23 Edwards

Edwards Lifesciences reports Q1 2026 results

Sales grew 16.7% to $1.65B; raises FY 2026 guidance to 9-11% sales growth and $2.95-$3.05 adjusted EPS.

Media coverage

Yesterday The Globe and Mail

Analysts Conflicted on These Healthcare Names: Edwards Lifesciences (EW), Xencor (XNCR) and Definitive Healthcare Corp (DH)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Edwards Lifesciences , Xencor and Definitive Healthcare Corp...

June 16 Seeking Alpha

Edwards Lifesciences hits 52-week high after Medicare coverage proposal

The U.S. Centers for Medicare & Medicaid Services proposed expanded coverage for TAVR procedures.

June 16 Yahoo Finance

CMS proposes Medicare coverage expansion for TAVR

Centers for Medicare and Medicaid Services on Monday proposed an updated national coverage determination for transcatheter aortic valve replacement that...

June 11 The Globe and Mail

Edwards Lifesciences' HPI Care Trial Posts Results, Offering Fresh Signals for Predictive Monitoring Investors

The HPI Care Trial, officially titled "A Randomized Trial of the Hypotension Prediction Index in the Cardiac Operating Room and the Intensive Care Unit," tested...

Never miss news about Edwards

Track Edwards and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Edwards competitors & trending companies

Browse news for competitors to Edwards and other trending companies.